期刊
NEURON
卷 85, 期 1, 页码 88-100出版社
CELL PRESS
DOI: 10.1016/j.neuron.2014.12.031
关键词
-
资金
- Telethon-Italy [GGP10037, TCP12013]
- Marie-Curie Reintegration Grants [FP7-256448, FP7-276981]
- Muscular Dystrophy Association [92333]
- National Institutes of Health (NIH) [1R01NS081303-01A1]
- ALS Association
- Robert Packard Center for ALS at Johns Hopkins
- NINDS-NIH
- EU Cost Action [TD0905]
- Boehringer Ingelheim
- Marie Curie International Outgoing Fellowships [PIO-GA-2011-300723]
Polyglutamine expansion in androgen receptor (AR) is responsible for spinobulbar muscular atrophy (SBMA) that leads to selective loss of lower motor neurons. Using SBMA as a model, we explored the relationship between protein structure/function and neurodegeneration in polyglutamine diseases. We show here that protein arginine methyltransferase 6 (PRMT6) is a specific co-activator of normal and mutant AR and that the interaction of PRMT6 with AR is significantly enhanced in the AR mutant. AR and PRMT6 interaction occurs through the PRMT6 steroid receptor interaction motif, LXXLL, and the AR activating function 2 surface. AR transactivation requires PRMT6 catalytic activity and involves methylation of arginine residues at Akt consensus site motifs, which is mutually exclusive with serine phosphorylation by Akt. The enhanced interaction of PRMT6 and mutant AR leads to neurodegeneration in cell and fly models of SBMA. These findings demonstrate a direct role of arginine methylation in polyglutamine disease pathogenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据